You're on our GLP-1 weight management page.   See the main practice →  ·  Request an introduction
Board-Certified Internist Former Mayo Clinic Faculty 20+ Years Faculty Experience

Medical Weight Management with GLP-1 Medications

Physician-supervised weight loss with semaglutide and tirzepatide. Prescribed and monitored by a board-certified internist at a small-panel practice in El Dorado Hills, CA.

GLP-1 medications are FDA-approved peptides — see our broader peptide therapy page for the full picture.

One flat monthly membership · founding-member rates · no per-visit charges · Cancel anytime · Hindi · Urdu · Punjabi spoken

Want the full picture of the practice?

See the main practice → Request an introduction
Sample ambulatory glucose profile showing a 2-week summary of glucose patterns — median curve, target range, and percentile shading reveal dawn rise and postprandial spikes that HbA1c misses

Companion Program

While you’re on GLP-1: see what your glucose actually does.

Most patients starting a GLP-1 also have prediabetes or metabolic syndrome. A 2-week diagnostic continuous glucose monitor, fasting insulin, HOMA-IR, and ApoB give us a real baseline — then we track how your glucose, insulin, and lipid profile actually respond to the medication, not just the scale.

See the Program Request an introduction

From Dr. Sahni

I spent 20 years as an internal medicine physician — Mayo Clinic, University of Minnesota faculty, complex chronic disease and obesity medicine. GLP-1s are genuinely transformative when prescribed for the right person with the right monitoring. They're also one of the most over-prescribed drug classes in 2026, often by services that never met the patient. I prescribe GLP-1s the way I'd prescribe to a family member: clinical indication required, brand medication only, metabolic and thyroid labs first, monthly check-ins to manage side effects and titration.

How we do GLP-1 differently

Most GLP-1 prescribing in 2026 happens through online questionnaires and shipped vials. Some patients do fine that way. Many don't.

How the Program Works

GLP-1 receptor agonists are among the most effective medications for weight management currently available. Originally developed for type 2 diabetes, medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have produced substantial weight loss in clinical trials. Individual response varies.

At Private MD, GLP-1 prescribing is supervised by a board-certified internist — not an online questionnaire. Your program includes:

Medications We Prescribe

Semaglutide

Brand names: Ozempic, Wegovy

A GLP-1 receptor agonist that reduces appetite and slows gastric emptying. FDA-approved for weight management (Wegovy) and type 2 diabetes (Ozempic). Weekly injection.

Tirzepatide

Brand names: Mounjaro, Zepbound

A dual GIP/GLP-1 receptor agonist with the highest weight loss results in clinical trials. FDA-approved for weight management (Zepbound) and type 2 diabetes (Mounjaro). Weekly injection.

The choice of medication is based on your medical history, metabolic profile, goals, and affordability. Your physician will discuss all options during your evaluation.

Questions? Get a quick answer.

Request an introduction

or call (916) 512-1912

Who Qualifies

GLP-1 medications for weight management are appropriate for adults who meet the following criteria:

Who should not take GLP-1 medications:

Your physician will review your full medical history, screen for contraindications, and assess your relationship with food and body image before prescribing. Patients with active eating disorders require specialized treatment before starting GLP-1 therapy. All patients complete a medical evaluation and informed consent before beginning treatment.

Pricing

GLP-1 is included in both of our membership plans — Direct Primary Care and Concierge Internal Medicine — for clinically indicated patients. See our programs →

GLP-1 medications (cash-pay) typically cost $149–449/month depending on the drug and manufacturer program (NovoCare, LillyDirect).

Why Private MD for GLP-1

Frequently Asked Questions

We prescribe semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound). The choice depends on your medical history, goals, and affordability.

Yes, you must be a member at any tier — Foundation, Signature, or Executive. GLP-1 prescribing for clinical indications (type 2 diabetes, BMI ≥30, metabolic conditions) is included at all tiers. Brand medications only (Ozempic, Mounjaro, Wegovy, Zepbound) — we don't prescribe compounded GLP-1s.

GLP-1 medications typically cost $149–449/month at current cash-pay pricing, depending on the drug and dose. Manufacturer programs (NovoCare, LillyDirect) offer direct self-pay pricing that has dropped significantly. Your physician will discuss pricing during your evaluation and help you find the most affordable option.

Yes. After your initial evaluation, most follow-up visits can be done via telemedicine. This is convenient for patients in Sacramento, Roseville, El Dorado Hills, Granite Bay, and the surrounding area.

The most common side effects are nausea, decreased appetite, and mild GI discomfort, particularly during dose increases. These usually improve with time. Less common but important risks include pancreatitis and gallbladder disease (gallstones), particularly with rapid weight loss. Some patients may also experience loss of lean muscle mass alongside fat loss — we monitor for this and may recommend protein targets and exercise guidance. Your physician will guide you through dose titration to minimize side effects.

Interested in GLP-1 Weight Management?

Tell us a bit about you and we'll reach out within one business day.

Request an introduction Call (916) 512-1912